1,789 results on '"Hohnloser, Stefan H."'
Search Results
202. Association of Different Estimates of Renal Function With Cardiovascular Mortality and Bleeding in Atrial Fibrillation
203. Rate, Time Course, and Predictors of Implantable Cardioverter Defibrillator Infections: An Analysis From the SIMPLE Trial
204. Cardiovascular outcomes, bleeding risk, and achieved blood pressure in patients on long-term anticoagulation with the thrombin antagonist dabigatran or warfarin: data from the RE-LY trial
205. Avoiding ICD lead revision in a patient with chronically low R-wave amplitudes
206. Dabigatran Dual Therapy Versus Warfarin Triple Therapy Post PCI in Patients With Atrial Fibrillation
207. Effects of Rivaroxaban on Biomarkers of Coagulation and Inflammation: A Post Hoc Analysis of the X-VeRT Trial
208. Rhythm or rate control in atrial fibrillation -- Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial
209. The Defibrillator in Acute Myocardial Infarction Trial (DINAMIT): study protocol
210. Dronedarone Therapy in Atrial Fibrillation: A Summary of Recent Controlled Trials
211. Efficacy and safety of dronedarone in patients with a prior ablation for atrial fibrillation/flutter: Insights from the ATHENA study
212. Dronedarone in patients with congestive heart failure: insights from ATHENA
213. Defibrillation Testing: The Need for a Definitive Trial
214. QT dispersion in exercise-induced myocardial hypertrophy
215. Prevention of implantable-defibrillator shocks by treatment with sotalol
216. Fighting with the invisible: radiation exposure in cardiac resynchronization therapy
217. Arrhythmic death in implantable cardioverter defibrillator patients: a long-term study over a 10 year implantation period
218. Assessment of Microvolt T-Wave Alternans in High-Risk Patients with the Congenital Long-QT Syndrome
219. Dronedarone in Atrial Fibrillation
220. Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications
221. Complications leading to surgical revision in implantable cardioverter defibrillator patients: comparison of patients with single-chamber, dual-chamber, and biventricular devices
222. How to analyze T-wave alternans
223. Highlights of Heart Rhythm 2005, the Annual Scientific Sessions of the Heart Rhythm Society, May 4–7, 2005, New Orleans, Louisiana
224. Stroke risk prediction in patients with atrial fibrillation with and without rheumatic heart disease.
225. Contributors
226. T-Wave Alternans
227. Risk Stratification Using T-Wave Alternans: More Questions Waiting to be Answered
228. Quantitative Analysis of the Duration of Slow Conduction in the Reentrant Circuit of Ventricular Tachycardia After Myocardial Infarction
229. Risks and Benefits of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin in Patients With Atrial Fibrillation According to Stroke Risk: The Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE-W)
230. Coronary Sinus Side Branches for Cardiac Resynchronization Therapy: Prospective Evaluation of Availability, Implant Success, and Procedural Determinants
231. Refinement of CARTO-guided substrate modification in patients with ventricular tachycardia after myocardial infarction
232. Amiodarone-associated macroscopic T-wave alternans and torsade de pointes unmasking the inherited long QT syndrome
233. Upgrading to biventricular pacing/defibrillation systems in right ventricular paced congestive heart failure patients: prospective assessment of procedural parameters and response rate
234. Rationale and Design of ATHENA: A Placebo-Controlled, Double-Blind, Parallel Arm Trial to Assess the Efficacy of Dronedarone 400 mg Bid for the Prevention of Cardiovascular Hospitalization or Death from Any Cause in PatiENts with Atrial Fibrillation/Atrial Flutter
235. Dronedarone vs. placebo in patients with atrial fibrillation or atrial flutter across a range of renal function: a post hocanalysis of the ATHENA trial
236. Dronedarone in Atrial Fibrillation
237. Tachycardia after pacemaker implantation in a patient with complete atrioventricular block
238. External cardioversion of atrial fibrillation in patients with implanted pacemaker or cardioverter-defibrillator systems: a randomized comparison of monophasic and biphasic shock energy application
239. Assessment of acute myocardial necrosis after cardiopulmonary resuscitation and cardioversion by means of combined thallium-201/technetium-99m pyrophosphate tomography
240. Radiofrequency catheter ablation in patients with symptomatic atrial flutter/tachycardia after orthotopic heart transplantation
241. Electrical storm in patients with an implantable defibrillator: incidence, features, and preventive therapy: insights from a randomized trial
242. Antiarrhythmic Therapy for Prevention of Implantable Cardioverter Defibrillator Shocks
243. Dronedarone: An Emerging Agent with Rhythm- and Rate-Controlling Effects
244. Can microvolt T-wave alternans predict mortality in patients with ischemic cardiomyopathy?
245. Acute Severe Cardiac Decompensation During Cardiac Resynchronization Therapy: What is the Cause?
246. Incidence of Atrial Tachyarrhythmias in Pacemaker Patients: Results from the Balanced Evaluation of Atrial Tachyarrhythmias in Stimulated Patients (BEATS) Study
247. Electrocardiographic Hallmark of Arrhythmogenic Right Ventricular Cardiomyopathy
248. Automated external defibrillation in emergency medical systems: what has been achieved and where to go?
249. Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence
250. Comparison of β-Blockers, Amiodarone Plus β-Blockers, or Sotalol for Prevention of Shocks From Implantable Cardioverter Defibrillators: The OPTIC Study: A Randomized Trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.